BACE1 regulates voltage-gated sodium channels and neuronal activity

Nature Cell Biology

Volumn 9, Issue 7, 2007, Pages 755-764

  Kim, Doo Yeon ^a   Carey, Bryce W ^a   Wang, Haibin ^a   Ingano, Laura A M ^a   Binshtok, Alexander M ^a   Wertz, Mary H ^a   Pettingell, Warren H ^a   He, Ping ^b   Lee, Virginia M Y ^c   Woolf, Clifford J ^a   Kovacs, Dora M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE; NEUROGENIC DIFFERENTIATION FACTOR; VOLTAGE GATED SODIUM CHANNEL;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL SURFACE; ENZYME ACTIVITY; ENZYME REGULATION; HIPPOCAMPUS; HUMAN; MOUSE; NERVE CELL; NERVE CELL EXCITABILITY; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SODIUM BLOOD LEVEL; SODIUM CURRENT; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; CELL LINE, TUMOR; CELL MEMBRANE; HIPPOCAMPUS; HUMANS; ION CHANNEL GATING; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEURONS; PATCH-CLAMP TECHNIQUES; PROTEIN SUBUNITS; RATS; SODIUM CHANNELS;

MUS MUSCULUS;

EID: 34347394695     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1602     Document Type: Article

References (44)

1. Assal, F. & Cummings, J. L. Neuropsychiatric symptoms in the dementias. Curr. Opin. Neurol. 15, 445-450 (2002).
2. Mendez, M. & Lim, G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 20, 791-803 (2003).
3. Hesdorffer, D. C., Hauser, W. A., Annegers, J. F., Kokmen, E. & Rocca, W. A. Dementia and adult-onset unprovoked seizures. Neurology 46, 727-730 (1996).
4. Hauser, W. A., Morris, M. L., Heston, L. L. & Anderson, V. E. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 36, 1226-1230 (1986).
5. Larner, A. J. & Doran, M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J. Neurol. 253, 139-158 (2006).
6. Isom, L. L. Sodium channel β subunits: Anything but auxiliary. Neuroscientist 7, 42-54 (2001).
7. Catterall, W. A. Molecular mechanisms of gating and drug block of sodium channels. Novartis Found. Symp. 241, 206-18 (2002).
8. Catterall, W. A. From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels. Neuron 26, 13-25 (2000).
9. Malhotra, J. D., Kazen-Gillespie, K., Hortsch, M. & Isom, L. L. Sodium channel β subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact. J. Biol. Chem. 275, 11383-11388 (2000).
10. Davis, T. H., Chen, C. & Isom, L. L. Sodium channel β 1 subunits promote neurite outgrowth in cerebellar granule neurons. J. Biol. Chem. 279, 51424-51432 (2004).
11. Chen, C. et al. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel β 2-subunits. Proc. Natl Acad. Sci. USA 99, 17072-17077 (2002).
12. Lopez-Santiago, L. F. et al. Sodium channel β2 subunits regulate tetrodotoxin-sensitive sodium channels in small dorsal root ganglion neurons and modulate the response to pain. J. Neurosci. 26, 7984-7994 (2006).
13. Catterall, W. A. Molecular properties of voltage-sensitive sodium channels. Annu. Rev. Biochem. 55, 953-985 (1986).
14. Lai, H. C. & Jan, L. Y. The distribution and targeting of neuronal voltage-gated ion channels. Nature Rev. Neurosci. 7, 548-562 (2006).
15. Vassar, R. et al. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741 (1999).
16. Sinha, S. et al. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 402, 537-540 (1999).
17. Fukumoto, H., Cheung, B. S., Hyman, B. T. & Irizarry, M. C. β-Secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 1381-1389 (2002).
18. Tyler, S. J., Dawbarn, D., Wilcock, G. K. & Allen, S. J. α- and β-secretase: Profound changes in Alzheimer's disease. Biochem. Biophys. Res. Commun. 299, 373-376 (2002).
19. Yang, L. B. et al. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer's disease. Nature Med. 9, 3-4 (2003).
20. Laird, F. M. et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 25, 11693-11709 (2005).
21. Kitazume, S. et al. Characterization of α 2,6-sialyltransferase cleavage by Alzheimer's β -secretase (BACE1). J. Biol. Chem. 278, 14865-14871 (2003).
22. Lichtenthaler, S. F. et al. The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J. Biol. Chem. 278, 48713-48719 (2003).
23. Willem, M. et al. Control of peripheral nerve myelination by the β-secretase BACE1. Science 314, 664-666 (2006).
24. Kim, D. Y., Ingano, L. A., Carey, B. W., Pettingell, W. H. & Kovacs, D. M. Presenilin/γ-secretase-mediated cleavage of the voltage-gated sodium channel β2-subunit regulates cell adhesion and migration. J. Biol. Chem. 280, 23251-23261 (2005).
25. Wong, H. K. et al. β subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase. J. Biol. Chem. 280, 23009-23017 (2005).
26. Koo, E. H. & Kopan, R. Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nature Med. 10, S26-S33 (2004).
27. Gong, B., Rhodes, K. J., Bekele-Arcuri, Z. & Trimmer, J. S. Type I and type II Na(+) channel α-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J. Comp. Neurol. 412, 342-352 (1999).
28. Whitaker, W. R. et al. Distribution of voltage-gated sodium channel α-subunit and β-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. J. Comp. Neurol. 422, 123-139 (2000).
29. Whitaker, W. R. et al. Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience 106, 275-285 (2001).
30. Meisler, M. H., Kearney, J., Ottman, R. & Escayg. A. Identification of epilepsy genes in human and mouse. Annu. Rev. Genet. 35, 567-588 (2001).
31. Dib-Hajj, S. D., Hinson, A. W., Black, J. A. & Waxman, S. G. Sodium channel mRNA in the B104 neuroblastoma cell line. FEBS Lett. 384, 78-82 (1996).
32. Chang, W. P. et al. In vivo inhibition of Abeta production by memapsin 2 (β-secretase) inhibitors. J. Neurochem. 89, 1409-1416 (2004).
33. Pertin, M. et al. Upregulation of the voltage-gated sodium channel β2 subunit in neuropathic pain models: Characterization of expression in injured and non-injured primary sensory neurons. J. Neurosci. 25, 10970-10980 (2005).
34. Lee, E. B. et al. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo. J. Cell Biol. 168, 291-302 (2005).
35. Schmidt, J. W. & Catterall, W. A. Biosynthesis and processing of the α subunit of the voltage-sensitive sodium channel in rat brain neurons. Cell 46, 437-444 (1986).
36. Thomas-Crusells, J., Vieira, A., Saarma, M. & Rivera, C. A novel method for monitoring surface membrane trafficking on hippocampal acute slice preparation. J. Neurosci. Methods 125, 159-166 (2003).
37. Zimmer, T. & Benndorf, K. The human heart and rat brain IIA Na+ channels interact with different molecular regions of the β1 subunit. J. Gen. Physiol. 120, 887-895 (2002).
38. Zhou, J., Yi, J., Hu, N., George, A. L., Jr. & Murray, K. T. Activation of protein kinase A modulates trafficking of the human cardiac sodium channel in Xenopus oocytes. Circ. Res. 87, 33-38 (2000).
39. Harrison, S. M. et al. BACE1 (β-secretase) transgenic and knockout mice; identification of neurochemical deficits and behavioral changes. Mol. Cell. Neurosci. 24, 646-655 (2003).
40. Rockenstein, E. et al. High β-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-β levels: Implications for the treatment of Alzheimer disease. J. Biol. Chem. 280, 32957-32967 (2005).
41. Hu, X. et al. Bace1 modulates myelination in the central and peripheral nervous system. Nature Neurosci. 9, 1520-1525 (2006).
42. Spampanato, J., Escayg, A., Meisler, M. H. & Goldin, A. L. Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J. Neurosci. 21, 7481-7490 (2001).
43. Claes, L. et al. De novo mutations in the sodium-channel gene SCNIA cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 68, 1327-1332 (2001).
44. Mendez, M. F., Catanzaro, P., Doss, R. C., ARquello, R. & Frey, W. H., 2nd. Seizures in Alzheimer's disease: Clinicopathologic study. J. Geriatr. Psychiatry. Neurol. 7, 230-233 (1994).